Recombinate
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
500 Kendall St, Cambridge, Massachusetts...Phone Number
(617) 349-0200Website
www.recombinate.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Recombinate
RECOMBINATE specializes in the treatment of hemophilia A through its recombinant Factor VIII concentrate. Launched in 1992, it revolutionized hemophilia care by providing effective control and prevention of bleeding episodes. Although RECOMBINATE is being discontinued, it has a well-established safety and efficacy profile based on extensive clinical studies. The intended clients are individuals with hemophilia A, requiring support in managing their condition.Explore more
Popular SearchesRecombinateRECOMBINATE[ Antihemophilic Factor( RecombinantSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Recombinate your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Recombinate has new funding data
Product Launch: Get notified when Recombinate launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Recombinate recently announced quarterly report
Click to see if Recombinate had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check out if Recombinate is spiking on competitors!
Recombinate, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Recombinate
Check if Recombinate has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Recombinate
Find 3 more new buyers
Compare Similar Companies to Recombinate
Compare insights from companies similar to Recombinate, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Company Profile Activity
Activity Insights
Recombinate is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Recombinate is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Recombinate.
Recombinate Tech Stack
A closer look at the technologies used by Recombinate
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Recombinate
Sign Up For FreeTo access detailed company insights
RECOMBINATE specializes in the treatment of hemophilia A through its recombinant Factor VIII concentrate. Launched in 1992, it revolutionized hemophilia care by providing effective control and prevention of bleeding episodes. Although RECOMBINATE is being discontinued, it has a well-established safety and efficacy profile based on extensive clinica... Read More
